Filter Results
:
(928)
Show Results For
-
All HBS Web
(928)
- People (2)
- News (64)
- Research (756)
- Events (1)
- Multimedia (2)
- Faculty Publications (650)
Show Results For
-
All HBS Web
(928)
- People (2)
- News (64)
- Research (756)
- Events (1)
- Multimedia (2)
- Faculty Publications (650)
- 01 Sep 2006
- News
Gift of Gab
then delivered a prepared talk on a topic of their choice. Subjects ranged from the pharmaceutical industry to the relative merits of cats vs. dogs, while Kim’s presentation took a humorous yet thoughtful...
View Details
- February 2002
- Case
Fighting AIDS and Pricing Drugs
In early 2001, makers of AIDS drugs were suing to prevent developing countries from violating their patents. The issue was driven by price. The developing countries could not afford the market price for these drugs. At the same time, the drug companies were reluctant...
View Details
Keywords:
Developing Countries and Economies;
Patents;
Price;
Strategy;
Globalized Markets and Industries;
Pharmaceutical Industry
Gourville, John T. "Fighting AIDS and Pricing Drugs." Harvard Business School Case 502-061, February 2002.
- Career Coach
Sarah Hoffner
industry as well as how to leverage career resources across HBS. She studied Public Health and History at Vanderbilt University and spent six years as a Client Service Lead at Entree Health, a pharmaceutical...
View Details
- 31 Oct 2004
- Research & Ideas
Bypass Marketing: Are Docs Influenced?
division president, Health Care, Harris Interactive; and Sandra Feibelmann, a member of the Institute for Health Policy. Manda Salls: When did the pharmaceutical industry begin direct-to-consumer...
View Details
Keywords:
by Manda Salls
- Fast Answer
Investing in Life Sciences - SIP Resources
healthcare, pharmaceuticals and biotech industries including policy and science developments, and overview of different technologies. Factiva - Covers news from national and local newspapers, magazines,...
View Details
- 01 Feb 2002
- News
Telling the Electronic Century's Unfinished Story
and pharmaceutical industries. But the differences between those pairs of sectors were just too great. So the second book will examine this question: Why were the Japanese chemical and pharmaceutical View Details
- 19 Sep 2017
- First Look
First Look at New Research and Ideas, September 19
in the pharmaceutical industry and lessen the strain both on patients and the healthcare system as a whole. However, doing so would require the company to raise capital, strengthen its sales force, and...
View Details
Keywords:
Sean Silverthorne
- 01 Dec 2004
- News
Finding a Balance
would otherwise be unable to afford treatment. Authored in 2003 by HBS professor Rohit Deshpandé, the case began as a straight pricing study. “The pharmaceutical industry is unlike any other,” Deshpandé...
View Details
- 01 Mar 2006
- News
Using IT to Heal U.S. Health Care
Association’s conference held on campus in early November. The three-day conference included presentations by industry executives, government officials, and HBS faculty on topics ranging from trends in the biotech and View Details
- 06 Feb 2007
- First Look
First Look: February 6, 2007
depression, led to a crisis in the industry. Nonetheless, the pioneering group of forecasters shaped the core problems, and invented many of the techniques, that influenced the maturation of the industry in the decades that followed....
View Details
Keywords:
Martha Lagace
- 27 Jun 2005
- Research & Ideas
The Potential Downside of Win-Win
allowed even when it will impose costs on parties who are away from the table. The U.S. pharmaceutical industry is one of the great success stories of the past century. If View Details
Keywords:
by Max H. Bazerman
- June 2013
- Supplement
Can PACIV (Puerto Rico) Serve European Customers? (Video Supplement)
By: Jim Sharpe
This is Video Supplement for Can PACIV (Puerto Rico) Serve European Customers? HBS Case #808099.
View Details
Keywords:
Entrepreneurial Management;
Global Organizations;
Service;
Hiring;
Incentives, Motivation;
Joint Ventures;
Customer Service Excellence;
Customer Relationship Management;
Empowerment;
International Expansion;
Ownership Structure;
Culture;
Organization Alignment;
Growth and Development Strategy;
Entrepreneurship;
Private Ownership;
Globalized Markets and Industries;
Globalized Firms and Management;
Pharmaceutical Industry;
Pharmaceutical Industry;
Puerto Rico;
United Kingdom
Sharpe, Jim. "Can PACIV (Puerto Rico) Serve European Customers? (Video Supplement)." Harvard Business School Video Supplement 813-722, June 2013.
- 24 Apr 2014
- News
Giving hope and inspiration to cancer patients around the globe
Every new day is a good day for Kathryn E. Giusti (MBA 1985) since that morning in 1996 when her oncologist told her to get her affairs in order because she had a rare blood cancer, with three years to live. Leveraging her past experience as a View Details
- 01 Feb 2001
- News
Drilling Down
The news last October of Chevron's proposed acquisition of Texaco for $36 billion in stock was hardly surprising to industry analysts. The planned merger — which would streamline projects and save some $1.2 billion annually — was...
View Details
- 25 Jun 2020
- News
Covering All Corners
Riad Armanious (MBA 2008) regards the pandemic as the greatest professional challenge he has faced as managing director of family-owned Eva Group and CEO of Eva Pharma, a multinational pharmaceutical company headquartered in Egypt. The...
View Details
- October 2000
- Case
Procter & Gamble Italy: The Pringles Launch (A)
By: Roy D. Shapiro
Procter & Gamble's (P&G) Pringles potato chips have been a very successful brand. This case reviews the development and first launch in the United States, then in markets around the world. Italy is one of the last countries where Pringles will be launched. Should P&G...
View Details
Keywords:
Globalized Markets and Industries;
Brands and Branding;
Marketing Strategy;
Product Launch;
Emerging Markets;
Product Development;
Adoption;
Value Creation;
Pharmaceutical Industry;
United States
Shapiro, Roy D. "Procter & Gamble Italy: The Pringles Launch (A)." Harvard Business School Case 601-070, October 2000.
- 29 May 2001
- Research & Ideas
Genomics: Can We Start Making Money Now?
don't survive clinical trials, resulting in the pharmaceutical industry footing enormous bills for failure. Genomics will be a productivity driver, pushing perhaps a 100 percent increase in drug development,...
View Details
Keywords:
by Sean Silverthorne
- 01 Dec 1996
- News
New Releases
computer industries, in which interfirm and international rivalries are intense. The other three consortia - Electric Power Research Institute (EPRI), Gas Research Institute (GRI), and Bell Communications Research (Bellcore) - draw their membership from regulated View Details
- 01 Jan 2003
- News
Daniel L. Vasella, M.D.
aspirations, purpose, and values, so that they work together as an aligned team." Dan Vasella finds that the skills he called upon as a practicing physician are equally useful in running one of the world's largest pharmaceutical...
View Details
- 01 Mar 2009
- News
A New Approach to Health-Care Reform
they know what disruptive innovation means, but I’ve found it’s often misunderstood. The simplest way to describe it — in a way that applies to health care or any industry — is innovation that transforms a product or service that...
View Details